Defunct Company
Total Trials
10
As Lead Sponsor
As Collaborator
0
Total Enrollment
4,611
NCT00740831
PGL4001 Versus GnRH-agonist in Uterine Myomas
Phase: Phase 3
Role: Lead Sponsor
Start: Aug 31, 2008
Completion: Jun 30, 2010
NCT00755755
PGL4001 Versus Placebo in Uterine Myomas
Start: Oct 31, 2008
Completion: Aug 31, 2010
NCT01156857
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
Start: Jul 31, 2010
Completion: Feb 29, 2012
NCT01252069
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study)
Start: Jan 31, 2011
Completion: Jan 31, 2014
NCT01635452
A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids
Phase: N/A
Start: May 31, 2012
Completion: Mar 31, 2016
NCT01629563
Start: Jun 30, 2012
Completion: Jan 31, 2015
NCT01630252
PGL5001 Proof of Concept Study in Inflammatory Endometriosis
Phase: Phase 2
Completion: Oct 31, 2013
NCT01631981
PGL2001 Proof of Concept Study in Symptomatic Endometriosis
Completion: May 31, 2014
NCT01642472
Start: Jul 31, 2012
Completion: Apr 30, 2015
NCT02748460
Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting
Start: Dec 22, 2015
Completion: Apr 11, 2024